France· FR:65711858
AZARGA 10 mg/mL + 5 mg/mL, collyre en suspension
A medicinal product containing maléate de timolol + brinzolamide, registered in France by NOVARTIS EUROPHARM (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE TIMOLOL + BRINZOLAMIDE
- Manufacturer
- NOVARTIS EUROPHARM (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip1334009391266471 flacon(s) polyéthylène basse densité (PEBD) de 5 ml avec embout(s)EUR 9.36
- cip1334009495000931 flacon(s) polyéthylène basse densité (PEBD) avec embout(s) de 5 ml (distributeur parallèle : MEDIWIN LIMITED)EUR 8.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maléate de timolol + brinzolamide in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAzarga 10mg/ml / 5mg/ml eye dropsDE Pharmaceuticals
- CzechiaAICYBETOmniVision GmbH, Puchheim
- SwedenAZARGA 10 mg/ml + 5 mg/ml Ögondroppar, suspensionNovartis Europharm Limited
- NetherlandsAicybet 10 mg/ml + 5 mg/ml oogdruppels, suspensieOmniVision GmbH
- GermanyBlizomitPharmathen S.A.
- ItalyAZARGANOVARTIS EUROPHARM LTD
- SpainAICYBET 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIONOmnivision Gmbh
- NorwayAzargaNovartis Europharm Limited (1)
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Brinzotim-Vision Sine
- Bulgaria · Бритосопт
- Czechia · Aicybet, Brinzolamid/Timolol Olikla
- Germany · Blizomit, Brinzloamid/Timolol Micro Labs
- Denmark · Brinzolamid/Timolol Medical Valley, Brinzolamide/Timolol Zentiva
- Estonia · Brinzolamide/Timolol Accord
- Spain · Aicybet, Blizomit
- United Kingdom (Northern Ireland) · Brinzolamide/Timolol Accord, Brinzolamide/Timolol Aspire
- Greece · Blizomit
- Iceland · Azarga, Brinzolamide/Timolol Stada
- Italy · Blizomit, Brintidox
- Liechtenstein · Azarga
- Lithuania · Brinzolamide/Timolol Accord
- Latvia · Brinzolamide/Timolol Accord, Brinzolamide/Timolol Zentiva
- Netherlands · Aicybet, Blizomit
- Norway · Azarga, Brinzolamid/Timolol Medical Valley
- Portugal · Blizomit
- Sweden · Brintidox, Brinzolamid/Timolol Medical Valley
- Slovakia · Brinzolamid/Timolol Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32616d7b-37df-414a-997a-4236cc12ed60 GET /v1/drugs/32616d7b-37df-414a-997a-4236cc12ed60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65711858",
"date_amm": "2008-11-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/482",
"substance": "MALÉATE DE TIMOLOL + BRINZOLAMIDE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en suspension",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about maléate de timolol + brinzolamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.